The global deuterated drugs market, valued at US$ 334.0 million in 2023, presents a robust growth pattern. With a projected valuation of US$ 871.8 million by 2032 at a CAGR of 11.25%, the market is ...

The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug containing the stable isotope — deuterium — in place of a hydrogen atom) to be approved by ...

Both drugs are JAK 1/2 inhibitors and have been ... as Opzelura for atopic dermatitis and vitiligo. Deuruxolitinib is a deuterated form of ruxolitinib, which Incyte claims in the lawsuit has ...